Comparative Study on Tolerance and Pharmacokinetics of Voriconazole for Injection in Healthy Subjects
Status:
Completed
Trial end date:
2020-09-16
Target enrollment:
Participant gender:
Summary
A single intravenous drip of voriconazole for injection developed by Qilu Pharmaceutical
(Hainan) Co., Ltd. and the original product "vfend" was given to healthy subjects ， The
pharmacokinetic differences and tolerance of the two preparations were evaluated at the doses
of 4mg / kg and 6mg / kg.